Purchase Order 36C24825P0009

Award Date 10/1/24
Potential Completion Date 9/30/29
Potential Value $731K
Awardee
Sofie CO.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sterling, VA, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 16 (VISN 16) of the U.S. Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie. The contract, valued at $690,810.00, is for the supply of FDG-F18 radiopharmaceuticals. Sofie is a subsidiary of Sofie Biosciences, Inc. that specializes in the development and delivery of molecular diagnostics and therapeutics, including radiopharmaceuticals for medical imaging and cancer treatment. The...
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 4 (VISN 4) of the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract, valued at $663,619.64, is for the supply of radiopharmaceuticals to support medical imaging and cancer treatment programs for veterans. Sofie is an experienced provider of specialized imaging agents, prostate cancer detection tools, and injectable cancer drugs to the VA, the Defense...
This is a firm-fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc., for the supply of Neuraceq Florbetaben F-18 Injections. The contract has a ceiling value of $427,500.00 and runs through September 30, 2024. The award was made without a set-aside designation, reflecting Sofie's established position as a specialized supplier of radiopharmaceuticals and related services to the VA. Sofie Biosciences, Inc. has extensive...
This is a $29,200 firm-fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract is for the supply of the radiopharmaceutical NEURACEQ (florbetaben F-18) to support medical imaging services at VA facilities. The contract is part of a larger Indefinite Delivery Vehicle (IDV) held by Sofie with the VA, which facilitates the ongoing procurement of specialized radiopharmaceuticals and related services....
This is a firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 4 (VISN 4) of the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract is for the supply of FDG and NEURACEQ radiopharmaceuticals, which are critical imaging agents used in medical diagnostic procedures, cancer detection, and treatment tracking. The contract has a ceiling value of $1,725,507.80 and a period of performance through April 30, 2025. Sofie...
This is a firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 2 (VISN 2), part of the U.S. Department of Veterans Affairs (VA), to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract is for the provision of emergency radiopharmaceuticals, with a ceiling value of $94,702.70 and a completion date of April 15, 2022. The contract does not have a set-aside designation. Sofie CO. is a specialized manufacturer and supplier of molecular diagnostics and...
This federal contract award, valued at $282,073.55, was issued by the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract is for the supply of radiopharmaceuticals, which are specialized imaging agents used in medical diagnostics and cancer treatment. The contract is a firm fixed-price purchase order and has a set-aside designation for small businesses. Sofie CO. is an experienced provider of radiopharmaceuticals, pharmaceuticals, and related...
This is a federal contract award to Sofie CO., doing business as Sofie, for the provision of PET radiopharmaceuticals to the Department of Veterans Affairs (VA). The contract, valued at $77,670.00, is a firm fixed-price purchase order with a completion date of September 30, 2018. Sofie is a subsidiary of Sofie Biosciences, Inc. and specializes in the development and delivery of molecular diagnostics and therapeutics, particularly PET imaging agents and cancer treatment products. The contract...
This federal contract award to Sofie CO. (doing business as Sofie), a subsidiary of Sofie Biosciences, Inc., was issued by the Veterans Integrated Service Network 10 (VISN 10) of the Department of Veterans Affairs (VA). The $1,306,250.00 delivery order is to exercise Ordering Period 2 and add 64 doses of a radiopharmaceutical PET product. The contract is a firm fixed-price award, with no set-aside designation. Sofie is an experienced supplier of radiopharmaceuticals, pharmaceuticals, and related...
This is a $509,597.82 firm fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract is for the delivery of PET radiopharmaceuticals. It has an ultimate completion date of April 14, 2024 and was awarded on April 15, 2023. Sofie CO. is an established prime contractor providing radiopharmaceuticals, pharmaceuticals, and related services to federal agencies like the VA, Defense Health Agency, and...

This is a $730,800 firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The contract is for the supply of Amyloid Florbetaben Injections, a radiopharmaceutical product, to the VA Healthcare System.

The award is not set aside and is a follow-on to a previous sole source contract issued by the VA's Network Contracting Office (NCO) 8 to Sofie for the supply of Neuraceq Florbetaben F-18 Injections to the VA Healthcare Center Miami. Sofie has extensive experience providing radiopharmaceuticals, pharmaceuticals, and related services to federal agencies including the VA, Defense Health Agency, and National Institutes of Health. The company holds several Indefinite Delivery Vehicles (IDVs) and Blanket Purchase Agreements (BPAs) with these agencies for a range of specialized medical imaging and cancer treatment products.

Generated 2/26/25, 9:56 AM